<DOC>
	<DOCNO>NCT00024544</DOCNO>
	<brief_summary>The purpose study evaluate investigational medication treat chronic asthma . The research conduct 20 clinical research sit US open men woman age 18 70 year . Participants study number visit research site 8-month period . All study-related care medication provide qualified participant cost . This include visit , examination laboratory work .</brief_summary>
	<brief_title>Pilot Study Patients With Symptomatic Steroid-Naive Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>At least 6month history asthma No use inhale , oral injectable steroid least 1 month prior enrollment Patients &gt; 10 pack year smoke history smoking within 12 month study enrollment No significant disease asthma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>asthma</keyword>
	<keyword>anti-IL-4 monoclonal antibody</keyword>
	<keyword>pascolizumab</keyword>
</DOC>